Alfaxalone provides reliable sedation for intradermal allergen testing in dogs and does not significantly affect results when compared to dexmedetomidine
Veterinary Dermatology · 2023
DOI: 10.1111/vde.13175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Dermatology, 2023. Verfasst von Courtney Meason und 2 weiteren Autor:innen. Beteiligte Einrichtung: BluePearl Veterinary Specialists, Spring, Texas, USA. Hauptthemen laut MEDLINE: Dexmedetomidine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: BluePearl University.
Abstract (Originalsprache)
Background
Dexmedetomidine (Dexmedetomidine hydrochloride‐Dexdomitor; Zoetis) is the preferred sedative used for canine intradermal allergen testing (IDT) in the United States. Alfaxalone (Alfaxan Multidose; Jurox Animal Health) is a neuroactive steroid, and its effect on sedation and allergen reactivity scores is unknown. Hypothesis/Objectives We hypothesised that alfaxalone would produce an adequate level of sedation with fewer cardiovascular adverse effects and would not affect allergen reactivity scores or histamine wheal size compared to dexmedetomidine. Materials and Methods Twenty client‐owned dogs were included in two groups: 10 atopic and 10 nonatopic. In a randomised, controlled, blinded, cross‐over design all dogs underwent two modified IDT, 1–4 weeks apart, using intravenous dexmedetomidine (2.87–5.22 μg/kg) or alfaxalone (1.8–2.4 mg/kg). Anaesthetic parameters and sedation level were recorded over 25 min using a validated canine sedation scale described by Grint et al. (Small Anim Pract, 2009, 50, 62). Simultaneously, both objective and subjective reactivity scores were measured in technical triplicates at 10, 15 and 20 min. The modified IDT included eight allergens, histamine‐positive and saline‐negative controls.
Results
Alfaxalone produced a significantly higher sedation score across all time points ( p < 0.05). All objective scores were significantly correlated to the corresponding subjective scores (Spearman R = 0.859, p < 0.0001). Sedative used did not significantly affect subjective allergen scores for nine atopic dogs ( p > 0.05, 15 min). Sedative used did not affect the diameter of objective scores for individual allergens and histamine wheals ( p > 0.05, 15 min). Conclusions and Clinical Relevance Intravascular alfaxalone is an alternative sedative for IDT in dogs. Alfaxalone may be preferred to dexmedetomidine in some clinical scenarios as a result of having fewer cardiovascular adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BluePearl Veterinary Specialists, Spring, Texas, USA.
Förderung
- BluePearl University
Zitieren
APA
Meason, C., Salazar, R., & Gentry, C. M. (2023). Alfaxalone provides reliable sedation for intradermal allergen testing in dogs and does not significantly affect results when compared to dexmedetomidine. Veterinary Dermatology. https://doi.org/10.1111/vde.13175
Vancouver
Meason C, Salazar R, Gentry CM. Alfaxalone provides reliable sedation for intradermal allergen testing in dogs and does not significantly affect results when compared to dexmedetomidine. Veterinary Dermatology. 2023. doi:10.1111/vde.13175
BibTeX
@article{Meason2023,
author = {Meason, Courtney and Salazar, Rebecca and Gentry, Christina M},
title = {Alfaxalone provides reliable sedation for intradermal allergen testing in dogs and does not significantly affect results when compared to dexmedetomidine},
journal = {Veterinary Dermatology},
year = {2023},
doi = {10.1111/vde.13175}
}
EUVIMED